Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Go back to Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: UNCY) Delayed: 6.85 -0.2 (2.84%)
Previous Close $7.05    52 Week High
Open $7.20    52 Week Low
Day High $7.33    P/E N/A 
Day Low $6.66    EPS
Volume 1,478,183